Unleashing the Power of Artificial Intelligence and Fusion Magnetic Resonance Imaging-Targeted Biopsy: Transforming Prostate Cancer Diagnosis

Louis Lenfant; Thomas Seisen; Morgan Rouprêt; Ugo Pinar; Pierre C Mozer

doi:10.1016/j.euo.2023.06.013

Unleashing the Power of Artificial Intelligence and Fusion Magnetic Resonance Imaging-Targeted Biopsy: Transforming Prostate Cancer Diagnosis

Eur Urol Oncol. 2023 Dec;6(6):541-542. doi: 10.1016/j.euo.2023.06.013. Epub 2023 Aug 14.

Authors

Louis Lenfant¹, Thomas Seisen², Morgan Rouprêt², Ugo Pinar², Pierre C Mozer³

Affiliations

¹ GRC 5, Predictive Onco-Urology, Sorbonne University, Department of Urology, Hôpital Pitié-Salpêtrière, AP-HP, Paris, France; CNRS UMR 7222, INSERM U1150, Institut des Systèmes Intelligents et Robotique, Sorbonne Université, Paris, France. Electronic address: louis.lenfant@aphp.fr.
² GRC 5, Predictive Onco-Urology, Sorbonne University, Department of Urology, Hôpital Pitié-Salpêtrière, AP-HP, Paris, France.
³ GRC 5, Predictive Onco-Urology, Sorbonne University, Department of Urology, Hôpital Pitié-Salpêtrière, AP-HP, Paris, France; CNRS UMR 7222, INSERM U1150, Institut des Systèmes Intelligents et Robotique, Sorbonne Université, Paris, France.

PMID: 37586959
DOI: 10.1016/j.euo.2023.06.013

Abstract

Advances in artificial intelligence (AI) and medical imaging have opened new avenues for the diagnosis and management of prostate cancer. In particular, AI technology can enhance the performance of fusion magnetic resonance imaging-targeted biopsy of the prostate, and has the potential to enhance the usability and precision of this biopsy technique, guide treatment decisions, and further advance prostate cancer care.

Publication types

Editorial

MeSH terms

Artificial Intelligence
Humans
Image-Guided Biopsy / methods
Magnetic Resonance Imaging
Male
Prostate* / pathology
Prostatic Neoplasms* / diagnostic imaging
Prostatic Neoplasms* / pathology
Ultrasonography, Interventional / methods